Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Thrombocytopenia
•
Hematology
•
Benign Hematology
•
ITP
When would you consider using fostamatinib monotherapy vs fostamatinib combined with TPO-RA for treatment refractory ITP?
Related Questions
How would you treat a young woman with refractory ITP surrounding pregnancy who responds to fostamatinib?
Patient with known ITP, now having a relapse in the setting of a mitral valve vegetation and responding to steroids and IVIG, would you consider a TPO agonist and wean steroids?
Is there a correlation between spleen size and degree of thrombocytopenia?
How do you manage drug-drug interactions between oral anticoagulants and the ARSI agents such as apalutamide and enzalutamide?
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
Would you complete a bone marrow biopsy for an unexplained macrocytosis without anemia?
Do you prefer avatrombopag over eltrombopag in ITP?
What are your options for refractory ITP after steroids and TPO for elderly patients?
In a patient with a history of HIT, how would you reintroduce Heparin?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
